Biosimilars offer affordable medical treatments, but regulatory guidelines need updating to ensure safety, efficacy, and ...

Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, predict pharmacy benefit managers (PBMs) will evolve toward value-based care, mirroring the broader shift toward open-cost ...

In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the evolution of women's inclusion in ...

Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of ...

This article is authored by Dr YK Gupta, president, AIIMS, Jammu and Ankush Kapoor, founder & CEO, Pharma NXT Biotech.

At the show, Synchron demonstrated how its Stentrode BCI, a stent-like device implanted via the neck into blood vessels near ...

Indeed, hematologists expect biosimilars’ arrival may in fact grow the overall ... include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & ...

The FDA defines a biosimilar as a biological product that is highly similar to an FDA-approved brand-name biologic drug (known as the reference product) used in the prevention or treatment of disease.

Objectives: Biosimilars offer a promising solution to challenges related to healthcare budget sustainability. However, limited patient awareness and understanding often hinder their timely adoption.

This is an extract from Our Human Story, our newsletter about the revolution in archaeology. Sign up to receive it in your inbox every month. Let’s talk about the biggest coincidence in human ...

Modern society may feel restrictive and too structured for people with ADHD. But what does the research say about how people lived with ADHD in the ancient past? For people with attention deficit ...